Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) Post Approval Study

NCT01660035 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.

NCT NCT01660035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01660035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) Post Approval Study
Lead sponsor
Medtronic
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
April 30, 2022
Enrollment
155 (actual)
Sites
123

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure